Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

OGN stock hub

Organon & Co. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.5B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

OGN

In the news

Latest news · OGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E3.9

P25 12.3P50 18.4P75 33.1

Trailing P/E14.2

P25 14.9P50 23.2P75 38.5

ROE34

P25 -105.6P50 -46.5P75 -3.1

ROIC6.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

261

Groups with data

Currency

USD

Showing 261 of 261 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001821825
Company name	Organon & Co.
Country	United States
Country code	US
Cusip	68622V106
Employees	10,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	$11B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - General
Isin	US68622V1061
Last refreshed	2026-05-10
Market cap	$3.5B
Market cap category	Mid-Cap
Price	$13.35
Price currency	USD
Rev Per Employee	616,300x
Sector	Healthcare
Sic	2834
Symbol	OGN
Website	https://www.organon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.02%
EV Earnings	44.55x
EV/EBIT	8.9x
EV/EBITDA	6.87x
EV/FCF	16.04x
EV/Sales	1.78x
FCF yield	19.48%
Forward P/E	3.86x
P/B ratio	3.88x
P/E ratio	14.16x
P/S ratio	0.57x
PE Ratio3 Y	5.58x
PE Ratio5 Y	5.94x
PEG ratio	1.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.99%
EBITDA Margin	25.88%
FCF margin	11.08%
Gross margin	53.84%
Gross Profit	$3.3B
Gross Profit Growth	-8.04%
Gross Profit Growth Q	-7.06%
Gross Profit Growth3 Y	-4.76%
Gross Profit Growth5 Y	-4.08%
Net Income	$246M
Net Income Growth	-67.2%
Net Income Growth Q	67.82%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-30.91%
Net Income Growth5 Y	-33.25%
Pretax Margin	8.71%
Profit Margin	3.99%
Profit Per Employee	$24,600
Profitable Years	8
ROA	5.89
Roa5y	8.46
ROCE	11.74
ROE	34.05
ROIC	6.51
Roic5y	16.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	53.91%
Cagr3y	-12.02%
Div CAGR3	-58.51%
EPS Growth	-67.25
EPS Growth Q	66.67
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-31.41
EPS Growth5 Y	-33.63
FCF Growth	-12.1%
FCF Growth Q	337.21%
FCF Growth3 Y	2.19%
FCF Growth5 Y	-24.43%
OCF Growth	-9.38%
OCF Growth Q	200%
OCF Growth3 Y	0.04%
OCF Growth5 Y	-22.42%
Revenue Growth	-2.08x
Revenue Growth Q	-3.5x
Revenue Growth Years	0x
Revenue Growth3 Y	0.1x
Revenue Growth5 Y	-0.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.47
Assets	$13B
Cash	$1.1B
Current Assets	$4.9B
Current Liabilities	$2.5B
Debt	$8.6B
Debt EBITDA	$5.15
Debt Equity	$9.49
Debt FCF	$12.55
Equity	$903M
Interest Coverage	2.51
Liabilities	$12.1B
Long Term Assets	$8.1B
Long Term Liabilities	$9.6B
Net Cash	$-7.5B
Net Cash By Market Cap	$-213
Net Debt EBITDA	$4.67
Net Debt Equity	$8.25
Net Debt FCF	$10.91
Tangible Book Value	$-4.3B
Tangible Book Value Per Share	$-16.56
WACC	5.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.97
Inventory Turnover	2.08
Net Working Capital	$1.3B
Quick ratio	1
Working Capital	$2.4B
Working Capital Turnover	$2.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.55%
Dividend Growth	-90.7%
Dividend Growth Years	0%
Dividend per share	$0.08
Dividend Years	6
Dividend Yield	0.6%
Ex Div Date	2026-05-11
Last Dividend	$0.02
Payout Frequency	Quarterly
Payout Ratio	8.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	53.87%
200-day SMA	8.54
3Y total return	-31.9%
50-day SMA	8.37
50-day SMA vs 200-day SMA	50under200
All Time High	39.48
All Time High Change	-66.18%
All Time High Date	2022-03-02
All Time Low	5.69
All Time Low Change	134.62%
All Time Low Date	2026-03-30
ATR	0.48
Beta	1.55
Beta1y	2.36
Beta2y	0.98
Ch YTD	86.19
High	13.37
High52	13.44
High52 Date	2026-05-06
High52ch	-0.67%
Low	13.28
Low52	5.69
Low52 Date	2026-03-30
Low52ch	134.62%
Ma50ch	59.42%
Premarket Change Percent	0
Premarket Price	$13.32
Price vs 200-day SMA	56.36%
RSI	77.97
RSI Monthly	50.26
RSI Weekly	70.14
Sharpe ratio	0.89x
Sortino ratio	1.69
Total Return	0.05%
Tr YTD	86.65
Tr1m	118.14%
Tr1w	0.45%
Tr3m	63.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	2
Analyst Price Target Top	$11.5
Analyst Ratings	Hold
Analyst Ratings Top	Hold
Earnings EPS Estimate	$0.84
Earnings EPS Estimate Growth	-17.65
Earnings Revenue Estimate	1,484,130,176x
Earnings Revenue Estimate Growth	-1.91x
Operating Income	$1.2B
Operating Income Growth	-13.06
Operating Income Growth Q	-18.26
Operating Income Growth3 Y	-7.78
Operating Income Growth5 Y	-12.72
Operating margin	19.99
Price target	$11.4
Price Target Change	$-14.61
Price Target Change Top	$-13.86

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	260,995,902%
Float Percent	99.39%
Net Borrowing	-487,000,000
Shares Insiders	0.51%
Shares Institutions	77.46%
Shares Out	262,600,862
Shares Qo Q	1.05%
Shares Yo Y	0.55%
Short Float	7.13%
Short Ratio	2.86
Short Shares	7.09

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$611M
Average Volume	17,602,604.5x
Bv Per Share	3.44
CAPEX	$-167M
Ch1m	118.1
Ch1w	0.45
Ch1y	52.4
Ch3m	62.61
Ch3y	-40.72
Ch6m	96.9
Change	0.23%
Change From Open	-0.07
Close	13.32
Days Gap	0.3
Depreciation Amortization	363,000,000
Dollar Volume	90,324,164.3
Earnings Date	2026-04-30
Earnings Time	bmo
EBIT	$1.2B
EBITDA	$1.6B
EPS	$0.94
F Score	6
FCF	$683M
FCF EV Yield	6.23x
FCF Per Share	$2.6
Financing CF	-524,000,000
Fiscal Year End	December
Founded	1,923
Goodwill	4,153,000,000
Graham Number	8.53855
Graham Upside	-36.04
Income Tax	$291M
Investing CF	168,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Lynch Fair Value	$4.71
Lynch Upside	-64.7
Ma150	8.1
Ma150ch	64.86%
Ma20	11.28
Ma20ch	18.31%
Net CF	569,000,000
Next Earnings Date	2026-08-04
Open	13.36
Optionable	Yes
P FCF Ratio	5.13
P OCF Ratio	4.12
Payment Date	2026-06-11
Position In Range	77.78
Post Close	13.35
Postmarket Change Percent	-0.15
Postmarket Price	$13.33
Ppne	1,279,000,000
Pre Close	13.32
Price Date	2026-05-08
Price EBITDA	$2.2
Relative Volume	0.38x
Revenue	6,163,000,000x
SBC By Revenue	1.17x
Share Based Comp	72,000,000
Tax By Revenue	4.72x
Tax Rate	54.19%
Tr6m	97.92%
Us State	New Jersey
Volume	6,765,855
Z Score	1.26

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

OGN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$0.08 annual per share

Payout ratio

+8.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.1%

Next ex-dividend date: 2026-05-11

Performance

OGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+77.5%

Float: +99.4% of shares outstanding

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

OGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

78.0

Above 70: short-term overbought

Price vs 200-day MA

+56.4%

50/200-day relationship not available

Beta (5Y)

1.55

More volatile than the market

Sharpe ratio

0.89

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current OGN stock rating?

Organon & Co. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full OGN analysis?

The full report lives at /stocks/OGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for OGN?

The latest report frames OGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the OGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.